High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
Saved in:
| Title: | High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster. |
|---|---|
| Authors: | Guirakhoo F; Vaxxinity Inc, Dallas, Texas, USA., Wang S; Vaxxinity Inc, Dallas, Texas, USA., Wang CY; United Biomedical Inc Asia, Hsinchu, Taiwan., Kuo HK; United Biomedical Inc Asia, Hsinchu, Taiwan., Peng WJ; United Biomedical Inc Asia, Hsinchu, Taiwan., Liu H; United Biomedical Inc Asia, Hsinchu, Taiwan., Wang L; Vaxxinity Inc, Dallas, Texas, USA., Johnson M; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Hunt A; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Hu MM; Vaxxinity Inc, Dallas, Texas, USA., Monath TP; Vaxxinity Inc, Dallas, Texas, USA., Rumyantsev A; Vaxxinity Inc, Dallas, Texas, USA., Goldblatt D; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2022 Oct 17; Vol. 226 (8), pp. 1401-1406. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35723969 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Guirakhoo+F%22">Guirakhoo F</searchLink>; Vaxxinity Inc, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Vaxxinity Inc, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Wang+CY%22">Wang CY</searchLink>; United Biomedical Inc Asia, Hsinchu, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kuo+HK%22">Kuo HK</searchLink>; United Biomedical Inc Asia, Hsinchu, Taiwan.<br /><searchLink fieldCode="AU" term="%22Peng+WJ%22">Peng WJ</searchLink>; United Biomedical Inc Asia, Hsinchu, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; United Biomedical Inc Asia, Hsinchu, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Vaxxinity Inc, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+M%22">Johnson M</searchLink>; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hunt+A%22">Hunt A</searchLink>; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hu+MM%22">Hu MM</searchLink>; Vaxxinity Inc, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Monath+TP%22">Monath TP</searchLink>; Vaxxinity Inc, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Rumyantsev+A%22">Rumyantsev A</searchLink>; Vaxxinity Inc, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Goldblatt+D%22">Goldblatt D</searchLink>; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2022 Oct 17; Vol. 226 (8), pp. 1401-1406. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35723969 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiac241 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1401 Titles: – TitleFull: High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guirakhoo F – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: Wang CY – PersonEntity: Name: NameFull: Kuo HK – PersonEntity: Name: NameFull: Peng WJ – PersonEntity: Name: NameFull: Liu H – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Johnson M – PersonEntity: Name: NameFull: Hunt A – PersonEntity: Name: NameFull: Hu MM – PersonEntity: Name: NameFull: Monath TP – PersonEntity: Name: NameFull: Rumyantsev A – PersonEntity: Name: NameFull: Goldblatt D IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 10 Text: 2022 Oct 17 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 226 – Type: issue Value: 8 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |